Quarterly report pursuant to Section 13 or 15(d)

Financial Instruments (Tables)

v3.24.1.1.u2
Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2024
Investments, All Other Investments [Abstract]  
Schedule of Cash and Cash Equivalents

The Company’s money market funds are categorized as Level 1 within the fair value hierarchy. As of March 31, 2024, the Company’s cash and cash equivalents were as follows:

 

 

 

 

 

Gross

 

 

 

 

 

Cash and

 

 

 

 

 

 

Unrealized

 

 

Fair

 

 

Cash

 

 

Cost

 

 

Losses

 

 

Value

 

 

Equivalents

 

Cash

 

$

90,733

 

 

$

 

 

$

90,733

 

 

$

90,733

 

Total

 

$

90,733

 

 

$

 

 

$

90,733

 

 

$

90,733

 

As of December 31, 2023, the Company’s cash and cash equivalents balances were as follows:

 

 

 

 

 

 

Gross

 

 

 

 

 

Cash and

 

 

 

 

 

 

Unrealized

 

 

Fair

 

 

Cash

 

 

 

Cost

 

 

Losses

 

 

Value

 

 

Equivalents

 

Cash

 

$

79,439

 

 

$

 

 

$

79,439

 

 

$

79,439

 

Total

 

$

79,439

 

 

$

 

 

$

79,439

 

 

$

79,439

 

Schedule of Contingent Consideration Liabilities Current and Non-current Balances

As of December 31, 2023, the Company’s contingent consideration liabilities current and non-current balances were as follows:

 

 

Fair Value as of

 

 

Changes in

 

 

Amount Paid

 

 

Fair Value as of

 

 

January 1, 2023

 

 

Fair Value

 

 

To Date

 

 

December 31, 2023

 

Level 3:

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration, current

 

$

8,067

 

 

$

1,651

 

 

$

(8,718

)

 

$

1,000

 

Contingent consideration, non-current

 

 

 

 

 

633

 

 

 

 

 

 

633

 

Total

 

$

8,067

 

 

$

2,284

 

 

$

(8,718

)

 

$

1,633